KR101848722B1 - 게실증의 치료를 위한 방법 및 조성물 - Google Patents

게실증의 치료를 위한 방법 및 조성물 Download PDF

Info

Publication number
KR101848722B1
KR101848722B1 KR1020177008405A KR20177008405A KR101848722B1 KR 101848722 B1 KR101848722 B1 KR 101848722B1 KR 1020177008405 A KR1020177008405 A KR 1020177008405A KR 20177008405 A KR20177008405 A KR 20177008405A KR 101848722 B1 KR101848722 B1 KR 101848722B1
Authority
KR
South Korea
Prior art keywords
glutamine
diverticulosis
compositions
salt
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177008405A
Other languages
English (en)
Korean (ko)
Other versions
KR20170038111A (ko
Inventor
유타카 니하라
Original Assignee
엠마우스 메디컬 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엠마우스 메디컬 인코포레이티드 filed Critical 엠마우스 메디컬 인코포레이티드
Publication of KR20170038111A publication Critical patent/KR20170038111A/ko
Application granted granted Critical
Publication of KR101848722B1 publication Critical patent/KR101848722B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1020177008405A 2011-12-19 2012-12-14 게실증의 치료를 위한 방법 및 조성물 Active KR101848722B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161630831P 2011-12-19 2011-12-19
US61/630,831 2011-12-19
PCT/US2012/000576 WO2013095681A1 (en) 2011-12-19 2012-12-14 Methods and compositions for the treatment of diverticulosis

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020147016785A Division KR20140103281A (ko) 2011-12-19 2012-12-14 게실증의 치료를 위한 방법 및 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020187009799A Division KR20180039187A (ko) 2011-12-19 2012-12-14 게실증의 치료를 위한 방법 및 조성물

Publications (2)

Publication Number Publication Date
KR20170038111A KR20170038111A (ko) 2017-04-05
KR101848722B1 true KR101848722B1 (ko) 2018-04-13

Family

ID=48669319

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020177008405A Active KR101848722B1 (ko) 2011-12-19 2012-12-14 게실증의 치료를 위한 방법 및 조성물
KR1020177020002A Ceased KR20170087531A (ko) 2011-12-19 2012-12-14 게실증의 치료를 위한 방법 및 조성물
KR1020147016785A Ceased KR20140103281A (ko) 2011-12-19 2012-12-14 게실증의 치료를 위한 방법 및 조성물
KR1020187009799A Ceased KR20180039187A (ko) 2011-12-19 2012-12-14 게실증의 치료를 위한 방법 및 조성물

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020177020002A Ceased KR20170087531A (ko) 2011-12-19 2012-12-14 게실증의 치료를 위한 방법 및 조성물
KR1020147016785A Ceased KR20140103281A (ko) 2011-12-19 2012-12-14 게실증의 치료를 위한 방법 및 조성물
KR1020187009799A Ceased KR20180039187A (ko) 2011-12-19 2012-12-14 게실증의 치료를 위한 방법 및 조성물

Country Status (13)

Country Link
US (4) US9616041B2 (OSRAM)
EP (2) EP3603631B1 (OSRAM)
JP (1) JP6060176B2 (OSRAM)
KR (4) KR101848722B1 (OSRAM)
CN (1) CN104114165B (OSRAM)
AU (1) AU2012355956B2 (OSRAM)
BR (1) BR112014014765A8 (OSRAM)
DK (1) DK2793875T3 (OSRAM)
ES (1) ES2770585T3 (OSRAM)
IN (1) IN2014KN01255A (OSRAM)
MX (1) MX351688B (OSRAM)
RU (2) RU2733396C2 (OSRAM)
WO (1) WO2013095681A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2733396C2 (ru) * 2011-12-19 2020-10-01 Иммаус Медикал, Инк. Способы и композиции для лечения дивертикулеза
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
EP3790545A4 (en) * 2019-07-17 2021-07-28 Emmaus Medical, Inc. METHODS AND COMPOSITIONS FOR TREATMENT OF SICKLE CLEANEMIA AND THALASSEMIA
US20230053227A1 (en) * 2021-07-27 2023-02-16 G&S Laboratories, Inc. Dietary fiber compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
US20040096479A1 (en) 2001-08-24 2004-05-20 Levine Scott David Ultra-high fiber supplement and method of cancer reduction
US20050058671A1 (en) 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2196053T3 (es) * 1994-01-11 2003-12-16 Stichting Zofia Procedimiento para el tratamiento de trastornos del cuerpo humano o animal mediante la administracion de aminoacidos.
JP2000060487A (ja) * 1998-08-27 2000-02-29 Kao Corp 便秘改善剤
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
US8512789B2 (en) * 2005-11-23 2013-08-20 The Coca-Cola Company High-potency sweetener composition with dietary fiber and compositions sweetened therewith
US20080003265A1 (en) 2006-06-28 2008-01-03 John Francis Casey Protein and fiber containing dietary supplement
EP2561766B1 (en) * 2006-11-07 2018-01-17 The Procter and Gamble Company Fiber containing compositions and methods of making and using same
RU2454730C1 (ru) * 2011-03-15 2012-06-27 Александр Михайлович Пузиков Способ лечения дивертикулеза в эксперименте
RU2733396C2 (ru) * 2011-12-19 2020-10-01 Иммаус Медикал, Инк. Способы и композиции для лечения дивертикулеза

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040096479A1 (en) 2001-08-24 2004-05-20 Levine Scott David Ultra-high fiber supplement and method of cancer reduction
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
US20050058671A1 (en) 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders

Also Published As

Publication number Publication date
RU2014123433A (ru) 2016-02-10
RU2733396C2 (ru) 2020-10-01
EP3603631A1 (en) 2020-02-05
MX351688B (es) 2017-10-25
US10258586B2 (en) 2019-04-16
WO2013095681A1 (en) 2013-06-27
EP2793875A1 (en) 2014-10-29
EP3603631B1 (en) 2023-11-29
US20190201361A1 (en) 2019-07-04
KR20170038111A (ko) 2017-04-05
KR20140103281A (ko) 2014-08-26
CN104114165B (zh) 2016-10-19
RU2662917C2 (ru) 2018-07-31
EP2793875B1 (en) 2020-02-05
AU2012355956B2 (en) 2016-07-21
BR112014014765A8 (pt) 2017-07-04
EP3603631C0 (en) 2023-11-29
AU2012355956A1 (en) 2014-07-03
US20130178531A1 (en) 2013-07-11
US9616041B2 (en) 2017-04-11
EP2793875A4 (en) 2015-06-03
JP2015500340A (ja) 2015-01-05
BR112014014765A2 (pt) 2017-06-13
KR20170087531A (ko) 2017-07-28
MX2014007382A (es) 2014-09-22
US20170157080A1 (en) 2017-06-08
CN104114165A (zh) 2014-10-22
JP6060176B2 (ja) 2017-01-11
RU2018126834A3 (OSRAM) 2019-04-25
US11304918B2 (en) 2022-04-19
DK2793875T3 (da) 2020-02-24
IN2014KN01255A (en) 2015-10-16
US20220202758A1 (en) 2022-06-30
ES2770585T3 (es) 2020-07-02
KR20180039187A (ko) 2018-04-17
RU2018126834A (ru) 2019-03-14

Similar Documents

Publication Publication Date Title
US20220202758A1 (en) Methods and compositions for the treatment of diverticulosis
JP5416327B2 (ja) タキサンにより惹起される神経毒性を予防又は軽減するための薬剤
TWI341728B (en) Combinations comprising epothilones and anti-metabolites
WO2022230920A1 (ja) 血中カルニチン増加剤
WO2010092436A1 (en) Pharmaceutical combinations of simethicone and otilonium
TW201803558A (zh) 腸內環境改善劑
JPH11116475A (ja) 炎症性腸疾患予防及び／又は治療剤
JP4355967B2 (ja) 医薬組成物
JP2024508514A (ja) 選択的ｃｂ２受容体アゴニストによる処置の方法
JP2016514142A (ja) 薬物及び栄養補助剤のバイオアベイラビリティを高める方法及び生成物
CN105106243A (zh) Bacteroides thetaiotaomicron VPI-5482在制备治疗或预防肥胖症药物中的应用
CN1477974A (zh) 抗肥胖剂和健康食品
JP5452042B2 (ja) 医薬組成物
JP6143215B2 (ja) 高脂肪食への嗜好性を軽減させるための医薬組成物、飲食品組成物または飲食品添加剤
JP6281919B2 (ja) 高脂肪食への嗜好性を軽減させるための医薬組成物、飲食品組成物または飲食品添加剤
WO2011100668A4 (en) Methods and compositions of civamide to treat diseases of the intestines
CN105377259A (zh) 提高药物和膳食补充剂的细胞吸收的方法和产品
JP5822420B2 (ja) 医薬組成物
JP2015231976A (ja) 心筋炎の予防または治療剤
JPWO2016199798A1 (ja) 運動誘発性の消化管障害の改善剤

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 9